LEADER 01443nam  2200445   450 
001 9910136575003321
005 20180410223400.0
010   $a1-5361-0228-8
035   $a(CKB)3710000000908027
035   $a(MiAaPQ)EBC4730539
035   $a(EXLCZ)993710000000908027
100   $a20161110h20162016  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aDrug development and rare pediatric diseases $eissues, strategic plan, and voucher program assessment /$fFrederick Johnston, editor
210  1$aNew York, [New York] :$cNova Biomedical,$d2016.
210  4$dİ2016
215   $a1 online resource (140 pages) $cillustrations, tables
225 1 $aPharmacology - Research, Safety Testing and Regulation
300   $aIncludes index.
311   $a1-5361-0227-X 
410  0$aPharmacology-research, safety testing, and regulation series.
606   $aPediatric pharmacology
606   $aDrug development
606   $aChildren$xDiseases$xTreatment
615  0$aPediatric pharmacology.
615  0$aDrug development.
615  0$aChildren$xDiseases$xTreatment.
676   $a615.1083
702   $aJohnston$b Frederick
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910136575003321
996   $aDrug development and rare pediatric diseases$92890079
997   $aUNINA